Organon (OGN) EBITDA Margin (2020 - 2026)
Organon's EBITDA Margin came in at 25.87% for Q2 2026, down 0.04 percentage points from 25.91% a year earlier but up 3.88 percentage points from the prior quarter.
Powered by 
Analysis
Organon (OGN) EBITDA Margin (2020 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Organon reported EBITDA Margin of 24.16%, down 0.68 percentage points year-over-year; for FY2025, it was 24.00%, down 3.05 percentage points from FY2024.
- EBITDA Margin carries a five-year change of -20.84 percentage points (FY2020 to FY2025).
- Going back by year, EBITDA Margin was 27.05% in FY2024 (+3.08 pp), 23.97% in FY2023 (-6.63 pp), 30.60% in FY2022 (-2.83 pp) and 33.42% in FY2021 (-11.42 pp).
- The five-year range for quarterly EBITDA Margin is 19.29% (Q3 2023) to 37.78% (Q1 2022).
- Year-over-year, EBITDA Margin increased in three of the last eight quarters, with an average year-over-year change of +0.13 percentage points.
- The fastest year-over-year change in EBITDA Margin over five years came in Q3 2024 (a gain of 9.72 percentage points), and the weakest in Q3 2023 (a drop of 10.96 percentage points).
- Business Quant data shows OGN's EBITDA Margin at 21.99% (Q1 2026), 20.31% (Q4 2025) and 28.09% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 39.10% |
| 10 | Organon | 3.60 Bn | 106.37 Mn | 847.00 Mn | 25.87% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 25.87% |
| Mar 31, 2026 | 21.99% |
| Dec 31, 2025 | 20.31% |
| Sep 30, 2025 | 28.09% |
| Jun 30, 2025 | 25.91% |
| Mar 31, 2025 | 21.35% |
| Dec 31, 2024 | 22.93% |
| Sep 30, 2024 | 29.01% |
| Jun 30, 2024 | 28.13% |
| Mar 31, 2024 | 28.11% |
| Dec 31, 2023 | 19.65% |
| Sep 30, 2023 | 19.29% |
| Jun 30, 2023 | 27.80% |
| Mar 31, 2023 | 29.06% |
| Dec 31, 2022 | 21.14% |
| Sep 30, 2022 | 30.25% |
| Jun 30, 2022 | 32.68% |
| Mar 31, 2022 | 37.78% |
| Dec 31, 2021 | 29.57% |
| Sep 30, 2021 | 35.50% |
API Access
Organon EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=OGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "OGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=OGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();